Who
Phillip Terry Meikle II
Director
Company insider
Files Form 4 as: Director, Bone Biologics.
In numbers
- Trades disclosed
- 5
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 16 Oct 2024
- Last trade
- 28 Sep 2026
- Last filed
- 30 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Sep 2026filed 30 Sep 2026 | BBLG Bone Biologicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —113,896 at $0.00 | filing |
| 28 Sep 2026filed 30 Sep 2026 | BBLG Bone Biologicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —113,896 at $0.00 | filing |
| 4 Jun 2025filed 6 Jun 2025 | BBLG Bone Biologicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —62,894 at $0.00 | filing |
| 16 Oct 2024filed 18 Oct 2024 | BBLG Bone Biologicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —9 at $0.00 | filing |
| 16 Oct 2024filed 18 Oct 2024 | BBLG Bone Biologicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —28,185 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.